𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Polymorphisms of methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), methionine synthase reductase (MTRR), and thymidylate synthase (TYMS) in multiple myeloma risk

✍ Scribed by Carmen S.P. Lima; Manoela M. Ortega; Margareth C. Ozelo; Renato C. Araujo; Cármino A. De Souza; Irene Lorand-Metze; Joyce M. Annichino-Bizzacchi; Fernando F. Costa

Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
133 KB
Volume
32
Category
Article
ISSN
0145-2126

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Genetic polymorphisms in the methylenete
Genetic polymorphisms in the methylenetetrahydrofolate reductase and thymidylate synthase genes and risk of hepatocellular carcinoma
✍ Jian-Min Yuan; Shelly C. Lu; David Van Den Berg; Sugantha Govindarajan; Zhen-Qua 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB 👁 1 views

Methylenetetrahydrofolate reductase (MTHFR) and thymidylate synthase (TYMS) are known to play a role in DNA methylation, synthesis, and repair. The genetic mutations in MTHFR and TYMS genes may have influences on their respective enzyme activities. Data on the association studies of the MTHFR and TY

Genetic polymorphisms in methylenetetrah
Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects
✍ Christensen, Benedicte; Arbour, Laura; Tran, Pamela; Leclerc, Daniel; Sabbaghian 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 47 KB 👁 2 views

Folic acid administration to women in the periconceptional period reduces the occurrence of neural tube defects (NTDs) in their offspring. A polymorphism in the gene encoding methylenetetrahydrofolate reductase (MTHFR), 677C¨T, is the first genetic risk factor for NTDs in man identified at the molec